PT842174E - Compostos heterociclicos para o tratamento da isquemia do miocardio - Google Patents
Compostos heterociclicos para o tratamento da isquemia do miocardioInfo
- Publication number
- PT842174E PT842174E PT96927083T PT96927083T PT842174E PT 842174 E PT842174 E PT 842174E PT 96927083 T PT96927083 T PT 96927083T PT 96927083 T PT96927083 T PT 96927083T PT 842174 E PT842174 E PT 842174E
- Authority
- PT
- Portugal
- Prior art keywords
- pct
- optionally branched
- compounds
- miocardio
- ischemia
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9509079A FR2737207B1 (fr) | 1995-07-26 | 1995-07-26 | Nouvelles n-heterocyclyl-1-aryloxyalcoyl-4-piperidinamines substituees, leur preparation et leur application en therapeutique |
Publications (1)
Publication Number | Publication Date |
---|---|
PT842174E true PT842174E (pt) | 2002-03-28 |
Family
ID=9481394
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT96927083T PT842174E (pt) | 1995-07-26 | 1996-07-25 | Compostos heterociclicos para o tratamento da isquemia do miocardio |
Country Status (17)
Country | Link |
---|---|
US (1) | US6011032A (pt) |
EP (1) | EP0842174B1 (pt) |
JP (1) | JPH11509857A (pt) |
KR (1) | KR19990035986A (pt) |
CN (1) | CN1103338C (pt) |
AT (1) | ATE206423T1 (pt) |
AU (1) | AU707950B2 (pt) |
BR (1) | BR9609911A (pt) |
CA (1) | CA2228691A1 (pt) |
DE (1) | DE69615696T2 (pt) |
DK (1) | DK0842174T3 (pt) |
ES (1) | ES2165514T3 (pt) |
FR (1) | FR2737207B1 (pt) |
MX (1) | MX9800705A (pt) |
NZ (1) | NZ315347A (pt) |
PT (1) | PT842174E (pt) |
WO (1) | WO1997005134A1 (pt) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2788775B1 (fr) * | 1999-01-22 | 2001-04-13 | Pf Medicament | Nouvelles n-alcoyl-n-[1-(omega-(arylalcoyloxy)alcoyl] piperidin-4-yl]-4h-3,1-benzo(thia/oxa)zines-2-amines substituees, leur preparation et leur application en therapeutique |
FR2788771B1 (fr) * | 1999-01-22 | 2001-04-13 | Pf Medicament | Nouvelles 1,2-alcoyl-1-[1-[aryl (alcoyl) oxyalcoyl] piperidin-4-yl]-3-aryl isothiourees substituees, leur preparation et leur application en therapeutique |
AU4314700A (en) * | 1999-04-28 | 2000-11-17 | Banyu Pharmaceutical Co., Ltd. | Processes for the preparation of piperidylmethylpyridine derivatives |
FR3001151B1 (fr) | 2013-01-21 | 2016-04-08 | Pf Medicament | Association d'un bloqueur de courant sodique lent et d'un inhibiteur du courant if sinusal et les compositions pharmarceutiques la contenant |
CN114349745B (zh) * | 2022-01-14 | 2023-12-08 | 黑龙江中医药大学 | 一种用于治疗心肌缺血的药物及其制备方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1260474A (en) * | 1984-12-03 | 1989-09-26 | Raymond A. Stokbroekx | Benzoxazol- and benzothiazolamine derivatives |
-
1995
- 1995-07-26 FR FR9509079A patent/FR2737207B1/fr not_active Expired - Fee Related
-
1996
- 1996-07-25 EP EP96927083A patent/EP0842174B1/fr not_active Expired - Lifetime
- 1996-07-25 ES ES96927083T patent/ES2165514T3/es not_active Expired - Lifetime
- 1996-07-25 JP JP9507283A patent/JPH11509857A/ja active Pending
- 1996-07-25 CN CN96196566A patent/CN1103338C/zh not_active Expired - Fee Related
- 1996-07-25 DE DE69615696T patent/DE69615696T2/de not_active Expired - Fee Related
- 1996-07-25 AU AU67031/96A patent/AU707950B2/en not_active Ceased
- 1996-07-25 AT AT96927083T patent/ATE206423T1/de not_active IP Right Cessation
- 1996-07-25 US US09/011,207 patent/US6011032A/en not_active Expired - Fee Related
- 1996-07-25 NZ NZ315347A patent/NZ315347A/xx unknown
- 1996-07-25 CA CA002228691A patent/CA2228691A1/fr not_active Abandoned
- 1996-07-25 DK DK96927083T patent/DK0842174T3/da active
- 1996-07-25 PT PT96927083T patent/PT842174E/pt unknown
- 1996-07-25 BR BR9609911A patent/BR9609911A/pt not_active IP Right Cessation
- 1996-07-25 WO PCT/FR1996/001176 patent/WO1997005134A1/fr not_active Application Discontinuation
- 1996-07-25 KR KR1019980700648A patent/KR19990035986A/ko not_active Application Discontinuation
-
1998
- 1998-01-23 MX MX9800705A patent/MX9800705A/es active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
ES2165514T3 (es) | 2002-03-16 |
FR2737207B1 (fr) | 1997-10-17 |
FR2737207A1 (fr) | 1997-01-31 |
EP0842174B1 (fr) | 2001-10-04 |
US6011032A (en) | 2000-01-04 |
WO1997005134A1 (fr) | 1997-02-13 |
MX9800705A (es) | 1998-10-31 |
AU707950B2 (en) | 1999-07-22 |
CN1103338C (zh) | 2003-03-19 |
CA2228691A1 (fr) | 1997-02-13 |
CN1193972A (zh) | 1998-09-23 |
EP0842174A1 (fr) | 1998-05-20 |
DE69615696T2 (de) | 2002-07-11 |
DK0842174T3 (da) | 2002-01-28 |
BR9609911A (pt) | 1999-03-02 |
AU6703196A (en) | 1997-02-26 |
ATE206423T1 (de) | 2001-10-15 |
JPH11509857A (ja) | 1999-08-31 |
KR19990035986A (ko) | 1999-05-25 |
NZ315347A (en) | 2000-01-28 |
DE69615696D1 (de) | 2001-11-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI974447A (fi) | Semikarbatsonit, joilla on keskushermostoaktiivisuutta, ja niitä sisältävät farmaseuttiset valmisteet | |
ATE205205T1 (de) | Durch hetero-aromatische ring substituierte phenyloxazolidinone als antimikrobielles mittel | |
HU9600278D0 (en) | Remedy for nervous diseases | |
DK0447285T3 (da) | Nephtalenderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler indeholdende dem | |
DK0874812T3 (da) | Hidtil ukendte 2,3,5-trimethyl-4-hydroxyanilidderivater, fremstilling deraf og terapeutisk anvendelse deraf | |
NO20015669L (no) | Heterocykliske substituerte aminoazacykler nyttige som sentralnervesystemmidler | |
RS49792B (sr) | Piperidinilaminometil trifluorometil ciklična etarska jedinjenja kao antagonisti supstance | |
HRP20000508B1 (en) | Substituted 2-benzylamino-2-phenyl-acetamide compounds | |
PT842174E (pt) | Compostos heterociclicos para o tratamento da isquemia do miocardio | |
DK0600950T3 (da) | Tetrazolamider som inhibitorer af ACAT | |
BR9508342A (pt) | Compostos orgânicos | |
ATE184593T1 (de) | Aminosäurederivate und ihre verwendung als phospholipase-a2-inhibitoren | |
WO2003022797A1 (fr) | Derives de carba-sucres amine et traitements du trouble du metabolisme des glycolipides les contenant en tant qu'ingredient actif | |
ATE173471T1 (de) | Pyridazinonderivate oder deren salze, verfahren zu ihrer herstellung und diese enthaltende antischockmittel | |
SV2002000302A (es) | Nuevos derivados de amidas heterociclicas ref. pc 10561/20140/bb | |
PT100682A (pt) | Agentes anti-helminticos derivados de benzimidazole e processo para a sua preparacao | |
DK0778839T3 (da) | Nye phosphanoxider, fremgangsmåde til deres fremstilling såvel som lægemidler indeholdende disse forbindelser | |
EA199800931A1 (ru) | Способ получения ингибиторов фосфодиэстеразы iv | |
MX9304444A (es) | Nuevos derivados de acido piridinecarboxilico, proceso para preparar los mismos. | |
DE3671014D1 (de) | Cyclohexan-1,3-dionderivate, diese enthaltende zusammensetzungen, verfahren zu deren herstellung und deren verwendung als herbizide und pflanzenwachstumsregulatoren. | |
AR018002A1 (es) | Composicion farmaceutica que comprende un anticonvulsivo y una resina de intercambio ionico para el tratamiento de la epilepsia, compuestos, uso de lapirrolidona polivinilica y proceso para preparar la composicion | |
MX9704976A (es) | Derivados de 1,2,3-benzotiadiazol. | |
RS49973B (sr) | Derivati rezorcinola | |
TH23898B (th) | วิธีการหยุดยั้งการออกฤทธิ์ของ il-6 |